Subscribe To
Vir stock gains on news of inclusion in the s&p smallcap 600
Vir Biotechnology (VIR) shares gain as the company is set to join the S&P SmallCap 600 effective prior to the opening of trading on Monday, Apr 4....
March 31, 2022, 12:47 pm
Pds biotechnology corporation (pdsb) ceo frank bedu-addo on q4 2021 results - earnings call transcript
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2021 Results - Earnings Call Transcript...
March 31, 2022, 12:34 pm
Netsceinttific notes 'steady progress' by portfolio company pds
NetScientific PLC (AIM:NSCI) says its portfolio company, PDS Biotechnology Corporation (NASDAQ:PDSB) (Nasdaq: PDSB), made good progress through 2021, ...
March 31, 2022, 10:36 am
Jasper therapeutics to present updated data on jsp191 conditioning in scid patients at the 2022 clinical immunology society annual meeting
REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic ce...
March 31, 2022, 8:00 am
Novavax asks eu regulator to clear covid vaccine for adolescents
The U.S. biotech has asked the European Medicines Agency to extend authorization of its Covid-19 shot t...
March 31, 2022, 7:21 am
Bayer to invest 2 billion euros in drug production over next 3 years
German drugmaker Bayer said it would invest around 2 billion euros ($2.23 billion) at pharmaceutical manufacturing sites over the next three years, ma...
March 31, 2022, 3:14 am
Risk-on biotech investors should buy cassava sciences
SAVA stock is volatile but worthwhile after opinion shifts in its favor. Remember, it has a blockbuster Alzheimer's drug nearing launch....
March 30, 2022, 6:18 pm
Why vir biotechnology stock is skyrocketing today
The S&P SmallCap 600 index will soon include Vir....
March 30, 2022, 12:40 pm
Vyant bio ends 2021 with $20.6m in cash as it sharpens focus on novel drug discovery
Vyant Bio (NASDAQ:VYNT) Inc ended its 2021 financial year with a beefed-up cash balance of $20.6 million to help the biotechnology company pursue its ...
March 30, 2022, 12:06 pm
Labcorp (lh) gains from covance arm growth, cost pressure ails
LabCorp's (LH) Covance Drug Development arm is benefiting from its collaborations with leading pharmaceutical and biotechnology companies....
March 30, 2022, 12:02 pm
Vir's stock is up 12% after news it will join the s&p smallcap 600
Shares of Vir Biotechnology Inc. VIR, +15.99% were up 12.8% in premarket trading on Wednesday, the day after it was announced that the stock will join...
March 30, 2022, 9:31 am
Cytodyn to hold webcast to provide company update
VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) -- Â CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology compan...
March 30, 2022, 8:30 am
Jazz pharmaceuticals to participate in upcoming april investor conferences
DUBLIN , March 29, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following upc...
March 29, 2022, 4:15 pm
Why igm biosciences stock rocketed higher today
In addition to reporting its fourth-quarter results, the clinical-stage biotech announced a lucrative n...
March 29, 2022, 11:41 am
Hookipa: speculative biotech with key catalysts in 2022
Hookipa: Speculative biotech With Key Catalysts In 2022...
March 29, 2022, 9:02 am
Tyme technologies shares jump premarket on news board to explore strategic options
Tyme Technologies Inc. TYME, -5.56% , a biotech developing cancer metabolism-based treatments, said Tue...
March 29, 2022, 8:01 am
Igm biosciences to host conference call and webcast today to discuss global collaboration agreement with sanofi
MOUNTAIN VIEW, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on crea...
March 29, 2022, 2:00 am
Make biotech cash considerations with sbio
In financial markets, it's often said that cash is king. That's something to remember when it comes to the biotechnology universe due to the cost-inte...
March 28, 2022, 8:59 pm
biotech is ‘oversold': top stocks to capitalize on the pullback
The SPDR S&P biotech ETF is down close to 25% year-to-date but Michael Yee sees several names in this s...
March 28, 2022, 8:40 pm
Amicus therapeutics among small biotechs cutting back
Amicus Therapeutics Inc. ( FOLD , Financial) is the poster child for the malaise affecting small biotechs, especially those working on gene and cell t...
March 28, 2022, 5:16 pm